Solid tumor
Conditions
Interventions
Au marker in 1.5mm diameter
Sponsors
Department of Radiation Oncology, Hokkaido University Graduate School of Medicine
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: 1) Age 20-yrs old or over at the time of consent form is obtained. 2) PS is 0-3 in the criteria of ECOG. 3) Patients who are considered to be capable for insertion of Au marker (2.0mm in diameter) to the prostate gland for radiotherapy. 4) Explained well and consent to this study.
Exclusion criteria
Exclusion criteria: 1) previous history of partial or total resection of prostate gland or bladder 2) the proposed radiation treatment site had been given tolerance dose in the past 3) cannot be held rest for about 30 minutes 4) weight over 135kg 5) with serious active infections in the irradiated sites 6) with severe diabetes that uncontrolled, or treated by using insulin 7) with pulmonary arteriovenous fistula, atrial heart septal defect, ventricular heart septal defect or other shunt between right and left heart 8) severe heart disease, or some serious complications, i.e., SLE, Scleroderma, interstitial pneumonia 9) with the state of DIC, bleeding tendency, who cannot halt the anticoagulant therapy even the temporary. 10) considered that participation in this trial is difficult because of psychiatric symptoms or psychosis 11) allergic to au materials. 12) unsuitable for enrollment judged by principal investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of the Au marker invisibility for the usage of patient localization before and during radiotherapy | — |
Secondary
| Measure | Time frame |
|---|---|
| Incidence of the Au marker migration at one month after completion of the radiotherapy | — |
Countries
Japan
Contacts
Public ContactShinichi Shimizu
Hokkaido University Graduate School of Medicine Department of Radiation Oncology
Outcome results
None listed